329 related articles for article (PubMed ID: 37357527)
21. COVID-19 Complications: Oxidative Stress, Inflammation, and Mitochondrial and Endothelial Dysfunction.
Georgieva E; Ananiev J; Yovchev Y; Arabadzhiev G; Abrashev H; Abrasheva D; Atanasov V; Kostandieva R; Mitev M; Petkova-Parlapanska K; Karamalakova Y; Koleva-Korkelia I; Tsoneva V; Nikolova G
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834324
[TBL] [Abstract][Full Text] [Related]
22. Possible routes of SARS-CoV-2 invasion in brain: In context of neurological symptoms in COVID-19 patients.
Kumar A; Pareek V; Prasoon P; Faiq MA; Kumar P; Kumari C; Narayan RK
J Neurosci Res; 2020 Dec; 98(12):2376-2383. PubMed ID: 32869376
[TBL] [Abstract][Full Text] [Related]
23. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
24. Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms.
Johansson A; Mohamed MS; Moulin TC; Schiöth HB
J Neuroimmunol; 2021 Sep; 358():577658. PubMed ID: 34304141
[TBL] [Abstract][Full Text] [Related]
25. Systematic Review of the Common Pathophysiological Mechanisms in COVID-19 and Neurodegeneration: The Role of Bioactive Compounds and Natural Antioxidants.
Choe K; Park HY; Ikram M; Lee HJ; Park TJ; Ullah R; Kim MO
Cells; 2022 Apr; 11(8):. PubMed ID: 35455977
[TBL] [Abstract][Full Text] [Related]
26. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
[TBL] [Abstract][Full Text] [Related]
27. SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article.
Taher T; Sheikh AB; Anwar F; Khosa F
Acta Neurol Belg; 2021 Apr; 121(2):331-339. PubMed ID: 33464546
[TBL] [Abstract][Full Text] [Related]
28. Brain Renin-Angiotensin System: From Physiology to Pathology in Neuronal Complications Induced by SARS-CoV-2.
Ahmadi S; Khaledi S
Anal Cell Pathol (Amst); 2023; 2023():8883492. PubMed ID: 37575318
[TBL] [Abstract][Full Text] [Related]
29. Mechanistic Insight and Possible Mechanism of Seizure in Covid-19: The Nuances and Focal Points.
Al-Kuraishy HM; Al-Gareeb AI; Rauf A; Alhumaydhi FA; Kujawska M; El-Saber Batiha G
CNS Neurol Disord Drug Targets; 2023; 22(6):875-883. PubMed ID: 35585806
[TBL] [Abstract][Full Text] [Related]
30. Neurological manifestations of COVID-19: with emphasis on Iranian patients.
Aslan C; Nikfarjam S; Asadzadeh M; Jafari R
J Neurovirol; 2021 Apr; 27(2):217-227. PubMed ID: 33710597
[TBL] [Abstract][Full Text] [Related]
31. A Comprehensive Review of COVID-19 Associated Neurological Manifestations.
Aggarwal CS; Walser S; Bhandari A; Garg N; McClafferty B; Ramgobin D; Golamari R; Sahu N; Kumar A; Jain R
S D Med; 2020 Dec; 73(12):569-571. PubMed ID: 33684975
[TBL] [Abstract][Full Text] [Related]
32. Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection.
Delgado-Roche L; Mesta F
Arch Med Res; 2020 Jul; 51(5):384-387. PubMed ID: 32402576
[TBL] [Abstract][Full Text] [Related]
33. Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications.
Ong WY; Go ML; Wang DY; Cheah IK; Halliwell B
Mol Neurobiol; 2021 Jan; 58(1):106-117. PubMed ID: 32897518
[TBL] [Abstract][Full Text] [Related]
34. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
[TBL] [Abstract][Full Text] [Related]
35. COVID-19's Clinical-Pathological Evidence in Relation to Its Repercussion on the Central and Peripheral Nervous System.
Morgado AM; Bezerra ALMS; Felix EBG; Júnior JCS; Pinto NB; Neto MLR; de Aguiar Rocha Martin AL
Adv Exp Med Biol; 2021; 1353():197-215. PubMed ID: 35137375
[TBL] [Abstract][Full Text] [Related]
36. The Impact of COVID-19 on People Living with HIV-1 and HIV-1-Associated Neurological Complications.
Dutta D; Liu J; Xiong H
Viruses; 2023 May; 15(5):. PubMed ID: 37243203
[TBL] [Abstract][Full Text] [Related]
37. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality.
Al-Kuraishy HM; Al-Gareeb AI; Al-Hussaniy HA; Al-Harcan NAH; Alexiou A; Batiha GE
Int Immunopharmacol; 2022 Mar; 104():108516. PubMed ID: 35032828
[TBL] [Abstract][Full Text] [Related]
38. Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients.
Veleri S
Exp Brain Res; 2022 Jan; 240(1):9-25. PubMed ID: 34694467
[TBL] [Abstract][Full Text] [Related]
39. The Effect of COVID-19 on NF-κB and Neurological Manifestations of Disease.
Davies DA; Adlimoghaddam A; Albensi BC
Mol Neurobiol; 2021 Aug; 58(8):4178-4187. PubMed ID: 34075562
[TBL] [Abstract][Full Text] [Related]
40. Neuropathogenesis of acute coronavirus disease 2019.
Farhadian SF; Seilhean D; Spudich S
Curr Opin Neurol; 2021 Jun; 34(3):417-422. PubMed ID: 33852526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
